DiscoverThe Business of Pharmacy Podcast™How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines
How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines

How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines

Update: 2024-06-24
Share

Description

In this episode, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines, discusses how PBM practices are opening doors to counterfeit drugs. Safdar explains the connection between under-reimbursement for pharmacies and the rise in counterfeit medications, shedding light on the critical need for policy changes to ensure drug safety.
https://www.safemedicines.org/
https://www.bizofpharmpod.com/



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines

How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines

Mike Koelzer, Pharmacist